Prohibitin: a potential biomarker for tissue-based detection of gastric cancer

被引：0
|
作者：
Xiangdong Kang
Long Zhang
Jian Sun
Zhenhua Ni
Yanchun Ma
Xiaobo Chen
Xia Sheng
Teng Chen
机构：
[1] Putuo Hospital Affiliated Shanghai University of Traditional Chinese Medicine,Central Laboratory
来源：
Journal of Gastroenterology | 2008年 / 43卷
关键词：
PHB; overexpression; gastric cancer; biomarker; tissue detection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：618 / 625
页数：7
相关论文
共 50 条
  • [21] Tissue-based prognostic markers in breast cancer
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 205 - 206
  • [22] Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology
    Chen, Debo
    Chen, Fenglin
    Lu, Xingrong
    Yang, Xiaosong
    Xu, Zhongbin
    Pan, Jie
    Huang, Ying
    Lin, Huiming
    Chi, Pan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) : 355 - 365
  • [23] Tissue-based cytokine immunotherapy for skin cancer
    Lokuta, M.
    Comer, A.
    Soto, B.
    Zanden, M. Vander
    Bucholtz, M.
    Allen-Hoffmann, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S100 - S100
  • [24] Prohibitin as a Potential Biomarker to Predict Osteoarthritis Progression
    Elseoudi, Abdellatif
    Elremaly, Wesam
    Elbakry, Mohamed
    Doucet, Roxanne
    Wang, DaShen
    Taheri, Maryam
    Pellicelli, Martin
    Picard, Cynthia
    Lavoie, Jean-Francois
    Lavigne, Patrick
    Lajeunesse, Daniel
    Moreau, Alain
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 144 - 144
  • [25] Sensitive electrochemical immunosensor to detect prohibitin 2, a potential blood cancer biomarker
    Yun, Young-Ran
    Lee, Seung Yeob
    Seo, Bokyung
    Kim, Hojin
    Shin, Myung Geun
    Yang, Sung
    TALANTA, 2022, 238
  • [26] Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
    Visser, Wieke C. H.
    de Jong, Hans
    Melchers, Willem J. G.
    Mulders, Peter F. A.
    Schalken, Jack A.
    CANCERS, 2020, 12 (12) : 1 - 20
  • [27] The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
    Monette, Anne
    Aguilar-Mahecha, Adriana
    Altinmakas, Emre
    Angelos, Mathew G.
    Assad, Nima
    Batist, Gerald
    Bommareddy, Praveen K.
    Bonilla, Diana L.
    Borchers, Christoph H.
    Church, Sarah E.
    Ciliberto, Gennaro
    Cogdill, Alexandria P.
    Fattore, Luigi
    Hacohen, Nir
    Haris, Mohammad
    Lacasse, Vincent
    Lie, Wen-Rong
    Mehta, Arnav
    Ruella, Marco
    Sater, Houssein Abdul
    Spatz, Alan
    Taouli, Bachir
    Tarhoni, Imad
    Gonzalez-Kozlova, Edgar
    Tirosh, Itay
    Wang, Xiaodong
    Gnjatic, Sacha
    CLINICAL CANCER RESEARCH, 2025, 31 (03) : 439 - 456
  • [28] Progress in the development of tissue-based biomarkers for urothelial cancer
    Bhanvadia, Raj R.
    Lotan, Yair
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (06) : 605 - 619
  • [29] Tissue-Based Biomarkers
    Reid, Glen
    Kao, Steven
    Van Zandwijk, Nico
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S57 - S58
  • [30] Unveiling the potential of prohibitin in cancer
    Koushyar, Sarah
    Jiang, Wen G.
    Dart, D. Alwyn
    CANCER LETTERS, 2015, 369 (02) : 316 - 322
12345